Eliminating malaria in our time

Caroline A Lynch^{1

2}, Karma Lhazeen³, Manash Shrestha^{1

2}, Varunika Ruwanpura⁴, Neena Valecha², Kamala Thriemer⁴

Affiliations

¹ Medicines for Malaria Venture (MMV), Geneva, Switzerland.
² Asia Pacific Malaria Elimination Network (APMEN) Vivax Working Group, Singapore, Singapore.
³ Department of Public Health, Ministry of Health, Thimphu, Bhutan.
⁴ Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.

Caroline A Lynch et al. PLOS Glob Public Health. 2024.

. 2024 Apr 17;4(4):e0003086.

doi: 10.1371/journal.pgph.0003086. eCollection 2024.

Caroline A Lynch^{1

2}, Karma Lhazeen³, Manash Shrestha^{1

2}, Varunika Ruwanpura⁴, Neena Valecha², Kamala Thriemer⁴

¹ Medicines for Malaria Venture (MMV), Geneva, Switzerland.
² Asia Pacific Malaria Elimination Network (APMEN) Vivax Working Group, Singapore, Singapore.
³ Department of Public Health, Ministry of Health, Thimphu, Bhutan.
⁴ Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.

No abstract available

Conflict of interest statement

The authors have declared that no competing interests exist.

1. World Health Organization. Global technical strategy for malaria 2016–2030, 2021 update. Geneva: World Health Organization; 2021. 1–40 p. https://apps.who.int/iris/rest/bitstreams/1357541/retrieve
1. Commons RJ, Rajasekhar M, Edler P, Abreha T, Awab GR, Baird JK, et al.. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2024;24(2): 172–83. doi: 10.1016/S1473-3099(23)00430-9 - DOI - PMC - PubMed
1. Watson JA, Commons RJ, Tarning J, Simpson JA, Llanos Cuentas A, Lacerda MVG, et al.. The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis. eLife. 2022;11:e83433. doi: 10.7554/eLife.83433 - DOI - PMC - PubMed
1. Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, et al.. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019;394(10202): 929–38. doi: 10.1016/S0140-6736(19)31285-1 - DOI - PMC - PubMed
1. Llanos-Cuentas A, Lacerda MVG, Hien TT, Vélez ID, Namaik-larp C, Chu CS, et al.. Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380(3): 229–41. doi: 10.1056/NEJMoa1802537 - DOI - PMC - PubMed